论文信息 - Epidermal growth factor receptor inhibition with erlotinib for palmoplantar keratoderma. - 字舞流文

Epidermal growth factor receptor inhibition with erlotinib for palmoplantar keratoderma.

M. Lacouture | A. Paller | B. Kenner‐Bell

[1] S. Steinberg,et al. Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2] Motonori Yamaguchi,et al. Distribution and function of EGFR in human tissue and the effect of EGFR tyrosine kinase inhibition. , 2003, Anticancer research.

[3] L. Requena,et al. Olmsted syndrome: report of a case with study of the cellular proliferation in keratoderma. , 2001, The American Journal of dermatopathology.

[4] Jean Kanitakis,et al. Olmsted Syndrome: Report of Two New Cases and Literature Review , 2000, The Journal of dermatology.